DIN 02450291 — LENVIMA 24 MG
LENVIMA is a capsule of Lenvatinib marketed by EISAI LIMITED. The full Lenvatinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02450291
- Brand name
- LENVIMA
- Active ingredient
- Lenvatinib
- Strength
- 24 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- EISAI LIMITED
- Health Canada status
- MARKETED
- Drug class
- Multi-kinase inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Lenvatinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02450321 | LENVIMA | 10 MG | CAPSULE | EISAI LIMITED | MARKETED |
| 02484129 | LENVIMA | 12 MG | CAPSULE | EISAI LIMITED | MARKETED |
| 02450313 | LENVIMA | 14 MG | CAPSULE | EISAI LIMITED | MARKETED |
| 02468239 | LENVIMA | 18 MG | CAPSULE | EISAI LIMITED | MARKETED |
| 02450305 | LENVIMA | 20 MG | CAPSULE | EISAI LIMITED | MARKETED |
| 02484056 | LENVIMA | 4 MG | CAPSULE | EISAI LIMITED | MARKETED |
| 02468220 | LENVIMA | 8 MG | CAPSULE | EISAI LIMITED | MARKETED |